EP Patent

EP3212288B1 — Formulations containing pomegranate seed oil, rosa canina fruit oil and inula viscosa oleoresin or extract

Assigned to Pomega Inc · Expires 2024-04-03 · 2y expired

What this patent protects

Patent listed against minocycline-hydrochloride.

Drugs covered by this patent

minocycline-hydrochloride (MINOCYCLINE HYDROCHLORIDE)

Patent Metadata

Patent number: EP3212288B1
Jurisdiction: EP
Classification: —
Expires: 2024-04-03
Drug substance claim: No
Drug product claim: No
Assignee: Pomega Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.